Journal Policy

Life and Science is committed to follow best practicing guidelines on editorial independence, code on good publication practices produced by Committee on Publication Ethics (COPE) and recommendation by International Committee of Medical Journal Editor (ICMJE).

  1. Author and Non-Author Contributors
The journal considers corresponding author as the one who takes primary responsibility for responding to editorial queries in a timely way during the manuscript submission, peer review, and publication process. The journal considers authorship on following four criteria as recommended by ICMJE:
  1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work
  2. Drafting the work or revising it critically for important intellectual content;
  • Final approval of the version to be published;
  1. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributors who meet fewer than all four of the above criteria for authorship are not considered as authors but as non-author contributors and should be acknowledged. It is the responsibility of the corresponding author, not the journal, to determine that all people named as authors meet all four criteria and to ensure non-author contributors are acknowledged. In case if submitted manuscript is authored by a group, the corresponding author should clearly identify the group name and members as authors. The journal requires submission of a signed Authorship and Contribution Declaration form by the corresponding author, clearly stating each author’s last name against following appropriate categories.
  1. Study conception and design
  2. Accusation of data
  • Analysis and interpretation of data
  1. Drafting of manuscript
  2. Critical revisions
The journal will not accept any request of removal or addition of an author after manuscript submission or publication.  
  1. Responsibilities of Authors, Journal, Reviewer and Publisher in the Submission and Review Process:
  1. Author:
Authors should abide by all principles of authorship and declaration of conflict of interest in the submission process.
  1. Journal:
The responsibilities of the journal in the submission and review process are as under:
  1. Confidentiality:
  • The journal considers manuscripts as author’s private communications which are not to be disclosed. The editors will not share information about manuscript and will safely store and archive the files. In case when a manuscript is not accepted, the editor will delete copies of it from their editorial systems.
  • When a manuscript is published the journals will keep copies of the original submission, reviews, revisions, and correspondence for at least three years.
  • Confidentiality may have to be breached if scientific misconduct is alleged, but editors will notify authors or reviewers if they intend to do so.
  1. Timeliness:
  • The journal follows a time-bared processing of manuscripts
  • The editor will ensure timely communication to the author regarding manuscript acceptance. Any planned delays in publication will be negotiated with the author.
  1. Peer Review:
  • It is the responsibility of the editor of journal to ensure selection of appropriate reviewers and that the reviewers have access to all relevant materials for evaluation.
  • However the journal is under no obligation to send submitted manuscripts for review, and to follow reviewer recommendations either favorable or negative, as the final decision for selection of all contents lies with the editor of the journal.
  • The journal acknowledges the contribution of peer reviewers to their journal by publishing their names.
  • As true scientific peer review begins only after the paper is published, the journal encourages the readers to submit comments, questions, or criticisms about published articles in letter to editor section. Authors will have a responsibility to respond appropriately.
  1. Integrity:
  • The editorial decision to consider publication of studies with findings that are not statistically significant or that have inconclusive or negative findings, is based upon the manuscript’s novelty, quality and scientific contribution.
  1. Reviewer:
  • It is the responsibility of the reviewer to keep manuscripts strictly confidential.
  • The reviewers must not retain the manuscript for their personal use and should destroy copies of manuscripts after submitting their reviews.
  • Reviewers are expected to respond promptly to requests to review and to submit reviews within the time agreed.
The journal considers conflict of interest when professional judgment concerning a primary interest (such as patients’ welfare or the validity of research) may be influenced by a secondary interest (such as financial gain). The journal requires that all participants in the peer-review and publication process including authors, peer reviewers, editors, and editorial board members must disclose all relationships that could be viewed as potential conflicts of interest. Submission of a signed disclosure of Conflicts of Interest certificate by all authors is mandatory. The manuscript will be published with the disclosure and sources of funding.
  1. Correction and Retractions / Republications and Version control
The journal discusses matters of debates as letters to the editor or as print/electronic correspondence, or as posts in a journal-sponsored online forum. The journal considers all updates of previous publications (e.g., an updated systematic review or clinical guideline) as new publication rather than a version of a previously published article A correction will be published in the journal if honest scientific error of fact is made The journal will follow ICMJE standards for publication of correction:
  • The journal will publish a correction notice as soon as possible detailing changes from and citing the original publication; the correction will be on the electronic or numbered print page that is included in an electronic or a print Table of Contents to ensure proper indexing.
  • The journal will also post a new article version with details of the changes from the original version and the date(s) on which the changes were
  • The journal will archive all prior versions of the article. This archive will be made available to the reader on
  • Previous electronic versions will prominently note that there are more recent versions of the
  • The citation will be to the most recent version
  • The journal will have the right to retract any published article if the scientific errors invalidate results, interpretations and
  • Retraction with republication by the journal will only be consider when the errors are judged to be unintentional, but has led to a major change in the direction or significance of the results, interpretations, and In this case, if the changed version of the paper survives further review and editorial scrutiny, only then retraction with republication of the changed paper will be considered, with an explanation to allow full correction of the scientific literature.
ii.   Scientific misconduct, expressions of concern and retraction: The journal encourages reviewers / readers to comment on ethical issues, validity of submitted research paper, so as to identify subtle and/or blatant type of plagiarism, research and publication misconduct (e.g. inappropriate research design, incomplete detail on participant’s consent, data manipulation)   Scientific misconduct includes data fabrication and falsification. Data falsification includes deceptive manipulation of images and plagiarism. Plagiarism is defined by HEC Plagiarism Policy as "taking and using the thoughts, writings, and inventions of another person as one's own". These include but are not limited to the following:
  • Verbatim copying, near-verbatim copying, or purposely paraphrasing portions of another author's paper or unpublished report without citing the exact
  • Copying elements of another author's paper, such as equations or illustrations that are not common knowledge, or copying or purposely paraphrasing sentences without citing the
  • Verbatim copying portions of another author's paper or from reports by citing but not clearly differentiating what text has been copied (e.g. not applying quotation marks correctly) and /or not citing the source
  • The unacknowledged use of computer programs, mathematical / computer models / algorithms, computer software in all forms, macros, spreadsheets, web pages, databases, mathematical deviations and calculations, designs / models / displays of any sort, diagrams, graphs, tables, drawings, works of art of any sort, fine art pieces or artifacts,
digital images, computer-aided design drawings, GIS files, photographs, maps, music / composition of any sort, posters, presentations and tracing.
  • Self-plagiarism that is, the verbatim or near-verbatim re-use of significant portions of one's own copyrighted work without citing the original
  The journal carries objective check through Turnitin and/or searching for similar titles to the submitted research paper. The journal will carry out individual assessment of each case of alleged scientific misconduct. An investigation committee headed by the editor will contact the corresponding author with his enclosed signed authorship statement and documentary evidence of misconduct, for an explanatory response. If the investigation proves scientific misconduct, then the journal will publish a retraction of the article. The journal will prominently label the retraction, on electronic or numbered print page or a print table of contents.
iii.  Copy right: The journal follows the Creative Common attribution non-commercial license.
iv.  Duplicate submission: The journal considers duplicate submission as submission of the same manuscript in same or different languages simultaneously to more than one journal. The journal does not accept any duplicate submission. Authors will require a signed declaration stating that the manuscript has not been submitted elsewhere. All submitted manuscripts without such signed declaration will be rejected.
v.   Duplicate and prior publication The journal considers duplicate publication as a publication of a paper that overlaps substantially with one already published, but without clear, visible reference to the previous publication. The journal does not accept any duplicate publication. The journal does not consider following as duplicate / prior publication:
  • A complete report that follows publication of a preliminary report, such as a letter to the editor, a preprint, or an abstract or poster displayed at a scientific
  • Any paper that has been presented at a scientific meeting but was not published in full
  • In the event of a public health emergency, information with immediate implications for public health should be disseminated without concern that this will preclude subsequent consideration for publication in a journal
 vi.  Acceptable secondary publication: The journal considers secondary publication as materials published in other journals or online justifiable and beneficial, especially when intended to disseminate important information to the widest possible audience (e.g., guidelines produced by government agencies and professional organizations in the same or a different language). The journal will consider secondary publications for all other reasons if the following ICMJE conditions are met:
  1. The authors have received approval from the editors of both journals (the editor concerned with secondary publication must have access to the primary version)
  2. The priority of the primary publication is respected by a publication interval negotiated by both editors with the authors
  3. The paper for secondary publication is intended for a different group of readers; an abbreviated version could be
  4. The secondary version faithfully reflects the data and interpretations of the primary version.
  5. The secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part elsewhere—for example, with a note that might read, “This article is based on a study first reported in the [journal title, with full reference]”—and the secondary version cites the primary
  6. The title of the secondary publication should indicate that it is a secondary publication (complete or abridged republication or translation) of a primary publication
  vii.   Manuscript based on the same data base: The journal considers all those manuscripts as independent submissions which are received from either separate research groups or from the same group analyzing the same data set (for example, from a public database, or systematic reviews or meta-analyses of the same evidence) because they may differ in their analytic methods, conclusions, or both. The journal will give preference to the manuscript submitted first if the data interpretation and conclusions are similar. Secondary analyses of clinical trial data should cite any primary publication and should clearly state that it contains secondary analyses/results, and use the same identifying trial registration number as the primary trial.
viii.  Correspondence: The journal has a mechanism for submitting  comments,  questions,  or  criticisms  about published articles through a correspondence section or online forum. Correspondence may be edited for length, grammatical correctness, and journal style and screen discourteous, inaccurate comments. Editors will have the prerogative to reject correspondence
ix.   Fees The journal may charge fees required for manuscript processing or publishing material.  
x.      Supplements The journal considers supplements as collections of papers that deal with related issues or topics, published as a separate issue of the journal or as part of a regular issue. The journal may publish supplements, theme issues, and special series from time to time. The same principles of authorship, conflict of interest, confidentiality, timeliness, peer-review, integrity, scientific misconduct and secondary publication, as discussed under relevant sections will also be applicable to supplements.
xi.    Electronic publishing The journal is published in electronic as well as print version and the policy applies equally to both. The journal does not endorse or take responsibility or liability for any content, advertising, products, or other materials on the external linked sites. The journal independently archive or use a credible repository for the historical record of published material.
xii.  Advertising The journal carries advertising on non-profit basis. The editors will have full and final authority for approving print and online advertisements and for enforcing advertising policy.
xiii. Clinical trial registration: The journal requires registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication.
Protection of Research Participants  
  • The journal requires submission of an Institutional Review Committee approval for all researches involving human data. However, approval by a responsible review committee does not prevent the journal editor from forming his own judgment about the ethical conduct of the research
  • When reporting experiments on animals, authors will indicate whether institutional and national standards for the care and use of laboratory animals were
  • The journal requires a written statement by the authors that they have received and archived written patient
Role of Publisher / Editor-In-Chief in Editorial 
  • It is the responsibility of Editor in Chief to appoint and dismiss
  • Editor in Chief will provide editors at the time of their appointment with a contract that clearly states their rights, duties, authority and the general terms of their
  • The editor’s performance will be assessed using mutually agreed-upon measures, including but not limited to readership, manuscript submissions, handling times and various journal
  • Appointments and dismissals will be based on evaluations by a panel of independent experts.
  • The journal adopts the World Association of Medical Editors definition of editorial freedom which states that editor in chief has full authority over the entire editorial content of their journal and the timing of publication of that He will also have the final authority in decisions about advertisements and sponsored content.
  • The editor in chief of journal has an independent editorial board for establishing and maintaining editorial policy and to support editorial
  • The editor in Chief will ensure that appropriate insurance is obtained in the event of legal action against the editors, and will ensure that legal advice is available when If legal problems arise, the editor will inform their legal adviser.
  • The editor will have  direct   access   to   the   highest   level   of   ownership, not to a delegated


Crossref Member Badge
Crossref Member Badge
Creative Commons License
Copyright © 2020 LifeandScience. All Right Reserved